Related Experiment Videos
[Positive inotropic agents: modelling, synthesis and SAR].
1Université Joseph Fourier, Faculté de Pharmacie de Grenoble, Meylan, France.
Journal De Pharmacie De Belgique
|January 1, 1991
Summary
Researchers identified a common pharmacophore in non-steroidal cardiotonics using computer modeling. This led to new pyridylquinolone compounds with significant positive inotropic and vasodilatory activities, potentially aiding congestive heart failure treatment.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Pharmacology
Context:
- Non-steroidal cardiotonic agents are crucial for managing congestive heart failure.
- Identifying common pharmacophores can guide the development of novel therapeutics.
- Computer-aided drug design offers powerful tools for molecular modeling and structure-activity relationship analysis.
Purpose:
- To identify a common pharmacophore among five non-steroidal cardiotonic agents using SYBYL computer modeling.
- To synthesize and characterize novel pyridylquinolone derivatives based on the derived pharmacophore model.
- To evaluate the synthesized compounds for positive inotropic and vasodilatory effects in vitro and in vivo.
Summary:
- A common pharmacophore was elucidated for non-steroidal cardiotonics via SYBYL modeling.
- A series of pyridylquinolone analogs were synthesized and their structure-activity relationships investigated.
- Several synthesized compounds demonstrated superior positive inotropic and vasodilatory activities compared to established references.
Impact:
- The study provides a novel class of pyridylquinolone compounds with potential therapeutic benefits for congestive heart failure.
- The identified pharmacophore serves as a valuable template for future drug discovery efforts in cardiotonic agents.
- This research highlights the efficacy of integrated computational and synthetic approaches in medicinal chemistry.